NCT02734043

Brief Summary

The objective of the study is to provide a road map that can help organizational leaders understand how to sequence their financial and human capital investments related to bundled payment arrangements. Although specific strategies will vary between organizations, providing evidence from a health system with extension experience bundling care for orthopedic joint replacements can be instructive for other providers entering new building arrangements. Insights from the experience of the health system can help other organizations prioritize effort and focus energy around strategies that increase the likelihood of succeeding under Comprehensive Care for Joint Replacement (CJR) and other bundled payment contracts.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Mar 2016

Typical duration for all trials

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2016

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

March 31, 2016

Completed
12 days until next milestone

First Posted

Study publicly available on registry

April 12, 2016

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2018

Completed
Last Updated

October 16, 2018

Status Verified

October 1, 2018

Enrollment Period

2.2 years

First QC Date

March 31, 2016

Last Update Submit

October 15, 2018

Conditions

Osteoarthritis

Keywords

bundled payment

Outcome Measures

Primary Outcomes (1)

  • Surgical site infection at the physician level

    The study team will evaluate at the physician level. The quality metric evaluated will be average rate of surgical site infections.

    12 months

Secondary Outcomes (6)

  • Cost of care during hospitalization

    12 months

  • Cost of care post-discharge

    12 months

  • All-cause readmission rate at the physician level

    12 months

  • Venous thromboembolism at the physician level

    12 months

  • Cost of care at the physician level

    12 months

  • +1 more secondary outcomes

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Orthopedic surgeons from one health system who participated over a five year span in bundled payment arrangements

You may qualify if:

  • participants in this study will be physicians participating in the bundled payment arrangement at the health system in question. All physicians will be included in the analysis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Osteoarthritis

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases
0

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PHD

Study Record Dates

First Submitted

March 31, 2016

First Posted

April 12, 2016

Study Start

March 1, 2016

Primary Completion

May 1, 2018

Study Completion

May 1, 2018

Last Updated

October 16, 2018

Record last verified: 2018-10

Data Sharing

IPD Sharing
Will not share